ALDH1A2 and non-small cell lung carcinoma: Finally, an in silico analysis of a cohort of 1570 NSCLC patients reveals that high expression of ALDH1A2, but not of ALDH1A1 or ALDH1A3, is associated with poorer prognosis (Supplementary Figure S3G).